Upgrade to Plus for the average price target, the upside write-up, and the analyst revenue forecast.
Cancel anytime. Secure checkout via Stripe.
| Quarter | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Firm | Action | Rating | Date |
|---|---|---|---|
| Zelman & Assoc | Upgrade | Neutral -> Outperform | Jul 17, 2026 |
| Goldman Sachs | Downgrade | Buy -> Neutral | Jul 7, 2026 |
| Barclays | Maintain | Overweight | May 8, 2026 |
| Wells Fargo | Maintain | Overweight | May 6, 2026 |
| RBC Capital | Maintain | Outperform | May 6, 2026 |
| Wells Fargo | Maintain | Overweight | Apr 8, 2026 |
| Truist Securities | Maintain | Buy | Feb 26, 2026 |
| Wells Fargo | Maintain | Overweight | Feb 25, 2026 |
| UBS | Maintain | Neutral | Feb 25, 2026 |
| RBC Capital | Maintain | Outperform | Feb 25, 2026 |
| Oppenheimer | Maintain | Outperform | Feb 25, 2026 |
| Barclays | Maintain | Overweight | Feb 25, 2026 |
Analyst estimates are third-party opinions, not guarantees. For information only.